A new member of the flavodoxin superfamily from Fusobacterium nucleatum that functions in heme trafficking and reduction of anaerobilin Original paper

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

February 13, 2026

  • Microbes
    Microbes

    Microbes are microscopic organisms living in and on the human body, shaping health through digestion, vitamin production, and immune protection. When microbial balance is disrupted, disease can occur. This guide explains key microbe types—bacteria, viruses, fungi, protozoa, and archaea—plus major pathogenic and beneficial examples.

Researched by:

  • Divine Aleru ID
    Divine Aleru

    User avatarI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

    Read More

Last Updated: 2026-02-13

Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.

Divine Aleru

I am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.

What was studied?

This study investigates the role of two proteins, HmuF and FldH, from Fusobacterium nucleatum in the anaerobic catabolism of heme. The research specifically focuses on their function in heme trafficking and reduction of anaerobilin, a product of heme degradation. The study delves into the biochemical properties of these proteins, their structural characteristics, and their roles in the bacterium’s iron acquisition strategy in anaerobic environments, particularly within the human body.

Who was studied?

The study utilized recombinant forms of HmuF and FldH expressed in Escherichia coli to examine their interaction with heme and FMN (flavin mononucleotide). The proteins were purified and analyzed for their binding properties and their enzymatic activities. Additionally, the research involved spectroscopic techniques, including UV-visible absorbance and mass spectrometry, to track the reduction of anaerobilin and heme. The role of these proteins in heme trafficking was further evaluated using biochemical assays and crystallographic techniques.

What were the most important findings?

The study discovered that both HmuF and FldH bind tightly to both heme and FMN, with HmuF playing a key role in trafficking heme to HmuW for further degradation. The crystal structure of Fe3+-heme-bound FldH revealed a helical cap domain that facilitates heme binding in proximity to the FMN cofactor, positioning it for subsequent reduction. This heme-loaded protein also functions as an anaerobilin reductase, catalyzing multiple reductions of anaerobilin, a toxic byproduct of heme degradation. Notably, the research demonstrated that the FMN cofactor in HmuF does not stabilize a semiquinone form as seen in typical flavodoxins, but instead participates in hydride transfer reactions, crucial for the reduction of the linearized tetrapyrrole. The study’s findings also suggest that HmuF and FldH work together to reduce the toxicity of anaerobilin by eliminating its electrophilic methylene group, providing the bacterium with a protective mechanism to handle heme degradation products in anaerobic conditions.

What are the greatest implications of this study?

The implications of this study are significant for understanding how Fusobacterium nucleatum survives and thrives in the human body, particularly in anoxic environments like the subgingival plaque or the colon. By elucidating the role of HmuF and FldH in heme trafficking and anaerobilin reduction, this research reveals critical steps in the bacterium’s iron acquisition pathway. These findings also open up potential therapeutic avenues, including the development of antimicrobial agents that target the unique enzymatic functions of HmuF and FldH. Disrupting this pathway could limit the bacterium’s ability to utilize heme and mitigate its pathogenic effects. Furthermore, the study suggests that inhibitors of heme trafficking or reduction could be used as part of a strategy to combat infections caused by F. nucleatum, including its involvement in periodontal disease and possibly even in cancer.

Fusobacterium nucleatum

Fusobacterium nucleatum is a Gram-negative, anaerobic bacterium commonly found in the oral cavity, where it plays a crucial role in the formation of biofilms. Beyond its presence in the mouth, Fn is implicated in a variety of systemic conditions, including periodontal disease, colorectal cancer, and inflammatory bowel disease. Known for its ability to coaggregate with other bacteria, Fn's pathogenic potential is magnified in dysbiotic microbial communities, making it a key player in polymicrobial infections. The bacterium utilizes multiple virulence factors such as FadA and Fap2, which facilitate adhesion to host tissues and immune evasion, ultimately contributing to its role in chronic and inflammatory diseases.

Join the Roundtable

Contribute to published consensus reports, connect with top clinicians and researchers, and receive exclusive invitations to roundtable conferences.